1/ Boris Johnson, the UK prime minister, said: “This is a local German decision and the EMA will, as I understand it, will be approving it for general use
2/ and I think that’s a very sensible of the EMA, because that is the vaccine our own MHRA has said produces an immune response in all age groups, as a good vaccine, so I’m confident about it.”
3/ From UK DHSC & MHRA report "Information for UK healthcare professionals on COVID-19 Vaccine AstraZeneca" bit.ly/3qXLBVN :
4/ "Elderly population Efficacy and safety data are currently limited in individuals greater than or equal to 65 years of age (see sections 4.8 and 5.1).

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Post-Polio News (ppn)

Post-Polio News (ppn) Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @postpolionews

26 Jan
1/ According to the MHRA, @MHRAgovuk , for the AstraZeneca vaccine, "Elderly population Efficacy and safety data are currently limited in individuals greater than or equal to 65 years of age (see sections 4.8 and 5.1)".
2/ See MHRA AstraZeneca document "REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS" bit.ly/3qXLBVN
Read 9 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!